Table 2.
Spectrum of driver oncogene mutations in 95 squamous cell carcinomas.
Gene | N (%) with mutation | 95% confidence intervals |
---|---|---|
EGFR | 0 | 0 – 3.8% |
KRAS | 0 | 0 – 3.8% |
PIK3CA | 4 (4.2%) | 1.2 – 10.4% |
AKT1 | 1 (1.1%) | 0 – 5.7% |
BRAF | 0 | 0 – 3.8% |
NRAS | 0 | 0 – 3.8% |
ERBB2/HER2 | 0 | 0 – 3.8% |
MAP2K1/MEK1 | 0 | 0 – 3.8% |
Any mutation | 5 (5.3%) | 1.7 – 11.9% |